Japan’s Ministry of Health, Labor and Welfare (MHLW) on March 5 unveiled the revised NHI prices for drugs subject to…
HOME > ARCHIVE
ARCHIVE
- METI to Support 386 Technological Development Projects
April 1, 2002
- New Standard Prices for Medical Materials Announced
April 1, 2002
- Takeda's New Invoice Prices More Closely Reflect Price Reductions Than Before
April 1, 2002
- REGULATORY NEWS IN BRIEF
April 1, 2002
- JIRA Is Enthusiastic about Forming New Medical Device Approval System
April 1, 2002
- REGULATORY NEWS IN BRIEF
March 25, 2002
- Supply of Good-quality Drug Information Should Be Promoted: JPMA Seminar
March 25, 2002
- Objective of Immediate PMS Is to Promote Proper Use of Drugs: JAPIC Seminar
March 25, 2002
- JPMA, CROs, SMOs to Jointly Solve Problems with Clinical Trials
March 25, 2002
- Simvastatin Inhibits Coronary Events in 3-lipid Abnormality Group: Banyu Seminar
March 25, 2002
- Sankyo, Yamanouchi Explain Genomics Strategies: Nomura Bio Conference 2002
March 25, 2002
- AstraZeneca's Development Capability in Japan at Int'l Level: R&D Executives
March 25, 2002
- WORLD NEWS IN BRIEF
March 25, 2002
- NTT DATA to Provide Free Software for Compressing Genome Data
March 25, 2002
- FDA Approves Gen-Probe's HIV-1, HCV Blood Screening Test
March 25, 2002
- Pharmagene Forms Its First Indication Switch Alliance with Sosei
March 25, 2002
- NHI Price Revision to Hit Companies Differently
March 25, 2002
- Takara Sets Up Target Protein Mass Production System in Tandem with UMDNJ
March 25, 2002
- Sales of Lipitor Increase by 216% to \40 Bil.: Mr Bootes of Pfizer
March 25, 2002
- Kyowa Hakko Discovers New Type of Mesenchymal Stem Cell
March 25, 2002
ページ
Japan is ramping up its push to spread regional formularies nationwide, a policy expected to standardize treatments, strengthen supply resilience,…
We had just gotten off a call with a client in Europe, and we’d received a bit of an earful. “Philip,” the client pressed, “what can this candidate bring to us? We know what he does, but what has he…
Japan’s Central Social Insurance Medical Council (Chuikyo) on November 5 approved the reimbursement listing for a slate of new medicines,…
The Japanese government on March 7 announced new NHI prices to be applied in the FY2025 drug price revision, revealing…
The Japanese government approved a bill to amend the Pharmaceuticals and Medical Devices (PMD) Act at its Cabinet meeting on…
Japan’s health ministry doled out regulatory approvals for a throng of new medicines on December 27 including Eli Lilly’s obesity…
Japan’s all-important reimbursement policy panel on December 20 approved an outline of drug pricing reforms for FY2024, which enshrines a…